Monitor the SEC's decision on the $5M MVLS Rule after the October 29 comment deadline. If the rule is reinstated, Artelo may need to raise capital, likely causing dilution. Watch for any ATM or equity-linked financing announcements.
Price Chart
Executive Summary
Artelo Biosciences disclosed that it was among ~180 Nasdaq-listed companies initially identified as having a market value of listed securities (MVLS) below the new $5M threshold. The $5M MVLS Rule is currently under a temporary stay, with a comment period on a proposed rule change open until October 29, 2026. The company has not committed to any specific action but may consider capital raises or other measures if the rule takes effect.
Key Facts
- Nasdaq's new $5M MVLS Rule was approved by the SEC on July 22, 2026.
- Artelo was among ~180 companies initially identified as having an MVLS below the $5M threshold.
- A temporary stay of the rule was announced on July 29, 2026.
- On October 5, 2026, the SEC published a Nasdaq proposal to make the rule operative upon termination of the stay; comments due October 29, 2026.
- The company may consider raising capital via its at-the-market equity program or other financings to regain compliance if the rule takes effect.
Financial Impact
Delisting risk if the $5M MVLS Rule is reinstated and Artelo cannot regain compliance; potential dilutive capital raise to boost market value.
Risk Factors
- Delisting from Nasdaq if MVLS remains below $5M and the rule takes effect.
- Potential shareholder dilution from equity or equity-linked financings to regain compliance.
- Uncertainty around the duration of the temporary stay and final rule terms.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001640334-26-001665 |
| Document: 0001640334-26-001665-index-headers.html | 0001640334-26-001665 |
| Document: 0001640334-26-001665-index.html | 0001640334-26-001665 |
| Document: 0001640334-26-001665.txt | 0001640334-26-001665 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | 8-K | $3.11 | awaiting T+60 | — | $2.20 (+29.26%) |
Sep 16, 2026 5w ago | Press Release | $3.75 | awaiting T+60 | — | $2.20 (−41.33%) |
Aug 13, 2026 10w ago | Press Release | $6.83 | awaiting T+60 | — | $2.20 (−67.79%) |
Jul 16, 2026 14w ago | DEFA14A | $1.14 $0.3622 | ▼ −68.23% | ▼ −71.94% | $2.20 (+92.98%) |
Jul 16, 2026 14w ago | Press Release | $1.14 $0.3622 | ▼ −68.23% | ▼ −71.94% | $2.20 (+92.98%) |
Jul 13, 2026 15w ago | Press Release | $1.05 $0.3844 | ▼ −63.39% | ▼ −67.38% | $2.20 (+109.52%) |
Jul 2, 2026 16w ago | DEFA14A | $1.11 $0.4522 | ▲ +59.26% | ▲ +60.98% | $2.20 (−98.20%) |
May 27, 2026 21w ago | 8-K | $1.46 $0.6920 | ▲ +52.60% | ▲ +54.34% | $2.20 (−50.68%) |
May 18, 2026 23w ago | 424B5 | $1.36 $0.7587 | ▼ −44.21% | ▼ −50.50% | $2.20 (+61.76%) |
May 15, 2026 23w ago | 8-K | $1.46 $0.7330 | ▼ −49.79% | ▼ −54.65% | $2.20 (+50.68%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers